Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Melanoma 9Neoplasms 7Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Glioblastoma 4Breast Neoplasms 4Urinary Bladder Neoplasms 3Sarcoma 3Prostatic Neoplasms 3Glioma 3Fallopian Tube Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Astrocytoma 3Skin Neoplasms 2Pancreatic Neoplasms 2Oligodendroglioma 2Neoplasms, Plasma Cell 2Myelodysplastic Syndromes 2Lung Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Head and Neck Neoplasms 2Central Nervous System Neoplasms 2Brain Neoplasms 2Uveal Melanoma 1Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Sarcoma, Synovial 1Sarcoma, Ewing 1

Interventions

Irinotecan 13Cyclophosphamide 11Vincristine 10Filgrastim 10Radiotherapy 9Ifosfamide 9Doxorubicin 9Dactinomycin 7Melphalan 6Granulocyte Colony-Stimulating Factor 6Etoposide 6cixutumumab 5Sirolimus 5Peripheral Blood Stem Cell Transplantation 5pegfilgrastim 4Topotecan 4Temozolomide 4Radiation 4Gemcitabine 4Busulfan 4temsirolimus 3sargramostim 3Granulocyte-Macrophage Colony-Stimulating Factor 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3trioctyl phosphine oxide 2regorafenib 2olaparib 2etoposide phosphate 2eribulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Rhabdomyosarcoma × poly ICLC × Clear all
NCT01241162 2017-05-09

Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma

University of Louisville

Phase 1 Completed
19 enrolled
CNSSarcoma

Neuroblastoma, Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡